Investor News Source Featured Stock Profile Innovest Global Inc. (OTCPINK:IVST) Acquires Stake in StemVax Therapeutics, Launching Biotechnology & Health Services Division
Investor News Source Featured Stock Profile: Innovest Global Inc. (OTCPink:IVST) (the "Company" or "Innovest"), a diversified holding company with operations in commercial and industrial products and services, launched its anticipated Biotechnology & Health Services Division today with the acquisition of a twenty percent interest in StemVax Therapeutics, a Translational Biotechnology Company that is currently developing a cancer vaccine therapy that enhances the patient's immune response against brain tumors.
View full press release